| Immunology of COVID-19: current state of the science N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ... Immunity 52 (6), 910-941, 2020 | 1700 | 2020 |
| TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer MD Park, I Reyes-Torres, J LeBerichel, P Hamon, NM LaMarche, ... Nature immunology 24 (5), 792-801, 2023 | 35 | 2023 |
| Kinesin-1 regulates antigen cross-presentation through the scission of tubulations from early endosomes in dendritic cells M Belabed, FX Mauvais, S Maschalidi, M Kurowska, N Goudin, JD Huang, ... Nature Communications 11 (1), 1817, 2020 | 19 | 2020 |
| An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis NM LaMarche, S Hegde, MD Park, BB Maier, L Troncoso, J Le Berichel, ... Nature 625 (7993), 166-174, 2024 | 9 | 2024 |
| On the biology and therapeutic modulation of macrophages and dendritic cells in cancer MD Park, M Belabed, ST Chen, P Hamon, S Hegde, R Mattiuz, TU Marron, ... Annual Review of Cancer Biology 7, 291-311, 2023 | 6 | 2023 |
| Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders CM Wilk, F Cathomas, O Török, J Le Berichel, MD Park, C Bigenwald, ... Immunity 56 (12), 2790-2802. e6, 2023 | 5 | 2023 |
| Immunology of COVID-19: current state of the science M Agrawal, M Aleynick, M Belabed, G Britton, M Brown, ... | 2 | 2020 |
| Circulating senescent myeloid cells drive blood brain barrier breakdown and neurodegeneration CM Wilk, F Cathomas, O Torok, J Le Berichel, MD Park, GR Heaton, ... bioRxiv, 2023.10. 10.561744, 2023 | 1 | 2023 |
| Abstract CT199: Rescuing response to ICI by blocking the type-2 immune axis in patients with NSCLC progressing on immunotherapy: A phase 1b/2 trial of dupilumab administered … TU Marron, NM LaMarche, MD Park, S Hegde, B Fitzgerald, C Hennequin, ... Cancer Research 83 (8_Supplement), CT199-CT199, 2023 | | 2023 |
| AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancer MDY Park, M Belabed, M Merad bioRxiv, 2023.12. 25.573303, 2023 | | 2023 |
| P2. 12-05 Cancer and Atopy: Parallel Drivers? IL-4 Blockade Synergizes with PD-L1 Blockade to Reverse Type-2Mediated Immunosuppression TU Marron, B Maier, NM LaMarche, S Hegde, M Belabed, R Mattiuz, ... Journal of Thoracic Oncology 17 (9), S153-S154, 2022 | | 2022 |
| Иммунология COVID-19: современное состояние науки M Agrawal, M Aleynick, M Belabed, G Britton, M Brown, ... | | |
